Substitution of liposomal bupivacaine for lidocaine reduces incidence of injection-emergent adverse events after intraarticular therapies for knee osteoarthritis: a prospective cohort study
With the substitution of LB for lidocaine, patients might have reported reduced incidence of AEs, mainly derived from the superiority in week 1. The substitution of LB for lidocaine was safe in different scenarios of IATs, and future randomized clinical trials were warranted by the current study.
Authors
- Hongyi Zhu (ORCID: https://orcid.org/0000-0001-9643-0790)
- Junqing Lin (ORCID: https://orcid.org/0000-0003-0498-4847)
- Tiexin Liu (ORCID: https://orcid.org/0009-0005-6599-221X)
- Qiuke Wang (ORCID: https://orcid.org/0000-0001-6439-6380)
- Zixuan Lin (ORCID: https://orcid.org/0000-0001-9462-7768)
- Lenian Zhou (ORCID: https://orcid.org/0000-0002-2355-1863)
- Tao Gao (ORCID: https://orcid.org/0000-0002-0789-9608)
Institutions
- Shanghai Jiao Tong University (CN)
- Shanghai Sixth People's Hospital (CN)
Publication Details
- Journal
- International Journal of Surgery
- Published
- 2024-12-20
- DOI
- https://doi.org/10.1097/js9.0000000000002192
- Citations
- 4
- Primary Topic
- Anesthesia and Pain Management
- Type
- article
- Field-Weighted Citation Impact
- 2.29